Products developed to treat the symptoms of Asthma and COPD provide one of the highest sources of revenue for the pharmaceutical industry. SMi’s 6th annual Asthma & COPD conference will present attendees with an exceptional line-up of speakers and an unrivalled forum for discussion and debate.

There will be an opportunity to hear about new research involving the use of bronchodilators and kinase-inhibitors as well as antibody based biologics. Presentations will also cover topics such as new therapeutic targets in asthma and COPD and optimising respiratory clinical trial data.

Why should you attend this event?

Hear about novel endpoints in COPD clinical trials Explore the application of in vitro cell models in drug development Learn about the use of the use of protein kinases as drug targets Discuss methods for candidate drug selection and risk management Network with industry associates and share experiences

Hear keynote addresses from:

• Peter Barnes, Head of Respiratory Medicine, Imperial College London
• Matthew Catley, Head of Respiratory Pharmacology, UCB

Our expert speaker line-up also includes:

Phillip Monk, Chief Scientific Officer, Synairgen Chris Compton, Vice President, Respiratory Franchise, Novartis Julien Giovannini, Team Manager, Early Development, AstraZeneca Peter Howarth, Senior Lecturer in Medicine, University of Southampton Mark Parry-Billings, Chief Executive Officer, Topigen Pharmaceuticals Harald Renz, Head of Clinical Chemistry and Molecular Diagnostics, University of Marburg   Gordon Dent, Senior Lecturer in Pharmacology, School of Medicine, Keele University Aleck J. Harrison, Consultant Clinical Scientist, AJH Partners Grant Sowman, Pulmonary Function Testing Specialist, Vitalograph Axel Fischer, Managing Director and Chief Operating Officer, Activaero Technologies

Who should attend?

Managers, Directors and Senior Scientists working at pharmaceutical or biotech organisations in the following areas:

Respiratory Science Research & Development Inflammation & Inhalation Clinical & Regulatory Affairs Drug Discovery Respiratory Illness

Inhalation Drug Delivery Project Management Preclinical Development Portfolio Management Marketing Drug Delivery

Venue details

London Marriott Hotel Regents Park 128 King Henry's Road London NW3 3ST Phone: +44 (0)207 722 7711 Fax: +44 (0)207 586 5822 Sales: +44 (0)207 449 4412 Sales fax: +44 (0)207 722 5973  www.marriott.co.uk/Regents-Park

Ideally located with easy access to London's major motorways, the London Marriott Hotel Regents Park is set in the quiet suburbs of Swiss Cottage; close to Lords Cricket Ground, London Zoo and the chic bars and restaurants of St Johns Wood and Primrose Hill. The nearby tube station offers direct access to Wembley and the O2 Centre, Bond Street, Westminster and Canary Wharf on the Jubilee line.

The only luxury North London hotel in Swiss Cottage, the London Marriott Hotel Regents Park promises a delightful stay, offering spacious rooms graced by amenities both pampering and practical - from luxurious new bedding to wireless Internet access. A tempting choice of dining includes the vibrant flavours of Brasserie Centrale and the casual Chat's Cafe Bar. To stay fit, a well-equipped leisure club and indoor pool awaits.

Nearest train station:
West Hampstead, 1.9 km

Nearest underground station:
Swiss Cottage (Jubilee line), 0.5 km, 5 min walk